← European Medicine Shortage Tracker · all medicines

Betametasone sodio fosfato shortage — availability across Europe

Availability information only — Mobi Doctor doesn't sell medicines; check with a pharmacy.

MEDICALLY REVIEWED
Dr. Chrysoula I. Liakou MD, PhD
Internal Medicine Specialist
Cancer Immunology Researcher
Reviewed 30 July 2026 · next review due 30 January 2027

Betametasone sodio fosfato currently has availability issues reported in 1 European register: Italy.

Shortage  ATC — · also listed as: BETAMETASONE SODIO FOSFATO · data refreshed 8 September 2026

Key facts

As of 8 September 2026, 1 of the 9 tracked registers list current availability issues for Betametasone sodio fosfato, covering 4 affected product presentations. The longest-running open report was filed in Italy on 2025-02-28 and has now been open for about 19 months. Where agencies state a cause, manufacturing problems lead with 4 of the 4 stated-cause reports. Registers in Italy indicate that alternatives or equivalents are available — a pharmacist or doctor can advise on switching.

WhereStatus & productsSinceExpected end Reason / alternativesSource
🇮🇹 ItalyShortage
BETAMETASONE DOC
+ 3 more products
BETAMETASONE DOC
BETAMETASONE EG
IBET
2025-02-28Problemi produttivi
Alternatives: AIFA: equivalents with the same active substance are available.
register ↗

New register reports per month

2025-02: 12025-03: 12025-04: 02025-05: 12025-06: 12025-022025-06

Full report history (4 register entries)

Every individual register entry for Betametasone sodio fosfato in the tracked sources, newest first — including resolved and discontinued reports.

Reg.ProductStatusReportedExpected endStated reason
🇮🇹 ITBETAMETASONE DOCShortage2025-06-30Problemi produttivi
🇮🇹 ITBETAMETASONE DOCShortage2025-05-15Problemi produttivi
🇮🇹 ITIBETShortage2025-03-10Problemi produttivi
🇮🇹 ITBETAMETASONE EGShortage2025-02-28Problemi produttivi

Frequently asked

Is Betametasone sodio fosfato currently in shortage in Europe?

Yes. As of 8 September 2026, availability issues are reported in: Italy. Availability is national — a shortage in one country does not mean it is short everywhere.

Are there alternatives to Betametasone sodio fosfato?

4 of the active register entries indicate alternatives or equivalents (same active substance or an alternative treatment). Do not switch on your own — a pharmacist or prescriber can confirm the right substitute in your country.

Where does this Betametasone sodio fosfato availability data come from?

Directly from the official medicines-agency register that lists Betametasone sodio fosfato: AIFA (Italy). Every row on this page links to the underlying official record, and the dataset is refreshed from the primary sources every morning. Cross-language matching groups the same active substance across registers, so national spellings all resolve to this page.

Embed this tracker

Pharmacies, patient sites and newsrooms are welcome to embed the live status of Betametasone sodio fosfato — free, with attribution. Copy this snippet:

<iframe src="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/betametasone-sodio-fosfato/embed.html" width="100%" height="150" loading="lazy" style="border:1px solid #e1e0d9;border-radius:12px" title="Betametasone sodio fosfato availability in Europe"></iframe>
<p style="font-size:12px">Source: <a href="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/betametasone-sodio-fosfato/">Betametasone sodio fosfato shortage status — European Medicine Shortage Tracker</a> by MobiDoctor</p>
Cite: “Betametasone sodio fosfato: availability status across 1 European registers — European Medicine Shortage Tracker (MobiDoctor), 8 September 2026.” Link this page and the agency record. Statuses come from the linked official registers and can change daily.